DAVID A RAMSAY

CIK 1283292 · Interim CFO · last filed 2026-04-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.33M

Companies

5

Total Filings

76

Lifetime Open-Market Net

$4.25M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HTI Interim CFO 364,320 -$33.8K 19 2026-04-02
SVRA Director 2,533,642 $5.26 $13.33M $3.85M 39 2025-12-19
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Director 97,000 $6.22 $603.3K $384.8K 9 2022-01-14
MSTX Director $16.18 $0 4 2017-01-23
Savara Inc (ANX) Delisted Director 100,000 $55.1K 4 2012-07-30

Recent Filings · Page 3 of 8

76 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-22 SVRA Buy (P) +100,000 $138.4K EDGAR
2022-01-14 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) $0 EDGAR
2021-12-30 SVRA Buy (P) +50,000 $64.0K EDGAR
2021-12-17 SVRA Buy (P) +40,000 $44.5K EDGAR
2021-12-14 SVRA Grant (A) $0 EDGAR
2021-12-13 SVRA Buy (P) +35,000 $36.4K EDGAR
2021-12-09 SVRA Buy (P) +25,000 $26.2K EDGAR
2021-12-06 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Buy (P) +24,500 $92.0K EDGAR
2021-12-02 SVRA Buy (P) +25,000 $27.1K EDGAR
2021-12-01 SVRA Buy (P) +25,000 $27.2K EDGAR
Showing 2130 of 76
Page 3 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.